The jury dismissed Elon Musk’s lawsuit against OpenAI—which alleged the organization had strayed from its nonprofit mission—on the grounds that it exceeded the statute of limitations. The legal battle, which spanned over two years, ultimately did not determine whether OpenAI had, in fact, deviated from its original commitments. Founded as a nonprofit entity in 2015, OpenAI later established for-profit subsidiaries and underwent a capital restructuring. After more than a decade of development, the original nonprofit was renamed the OpenAI Foundation. It now holds a 26% stake in the OpenAI Group and has the authority to appoint all of the Group’s directors. Following the restructuring, the Foundation’s stake is estimated to be worth approximately $130 billion. It has made an initial commitment to invest $25 billion in two key areas: health and disease eradication, and AI resilience. Currently, the Foundation has announced grants totaling over $125 million for health and life sciences data, with a particular focus on addressing Alzheimer’s disease, building public health data infrastructure, and researching diseases with high burdens. It prioritizes supporting the development of datasets that hold significant public value. Despite the Foundation’s emphasis on its independence and its dedication to making data accessible to researchers globally, it still maintains structural connections with OpenAI in terms of resource acquisition and business strategy. Whether it can genuinely fulfill its founding mission of benefiting all of humanity remains uncertain and will depend on the implementation of future governance frameworks and the verification of outcomes from open data-driven scientific research.